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Introduction
Mastitis is the most frequent and costly disease
that affects dairy cows. Viral infections, such as
those caused by the pseudo cowpox virus, can in-
duce teat lesions that negatively reduce the natural
defense mechanisms of the udder and indirectly
lead to infiltration of bacterial pathogens that cause
bovine mastitis (Turner et al., 1976; Francis, 1984;
Scott and Holliman 1984). Thus, viral infections
may play an indirect role in bovine mastitis, due to
their immunosuppressive properties (Wellenberg et
al., 2002). Although multiple pathogens are asso-
ciated with bovine mastitis, Staphylococcus aureus
is a common and important cause of the disease
(Cao and Hu, 2010) and has proved more difficult
to control and treat despite the best possible antimi-
crobial treatments utilized (Barkema et al., 2006).
Achieving a cure for a mastitis case is highly de-
pendent on host immunity and specific character-
istics of the infective organism; thus, antimicrobial
susceptibility tests are not always accurate in pre-
dicting clinical outcomes (Apparao et al., 2009;
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ABSTRACT
Mastitis is the most common and most expensive disease that impacts dairy farms in Egypt.
In this study, we investigated bacterial mastitis cases that did not respond to antimicrobial
treatment from buffaloes and cows. Milk samples (11) were collected from diseased animals
(5 buffaloes and 6 cows). The samples were tested microbiologically to isolate and identify
the causative bacteria and antimicrobial susceptibility. The antimicrobial sensitivity of the
isolated bacteria was tested by using minimum inhibitory concentration technique according
to the clinical national laboratory standards.  The total number of bacterial isolates from
the cases was 15 isolates. Staphylococcus aureus (S. aureus) was isolated alone in two cases
(13.33% of the isolates), and S. aureus isolated in combination with Arcanobacterium pyo-
genes (A. pyogenes) in one case (6.67%), and S. aureus isolated in combination with both
A. pyogenes and Streptococcus agalactiae (S. agalactiae) in two cases (13.33%), and Co-
agulase negative staphylococci (CNS) isolated alone in one case (6.67%), and CNS isolated
in combination with Klebsiella pneumoniae in one case (6.67%), and A. pyogenes isolated
alone in two cases (13.33%). In two cases were not able to isolate any bacterial pathogen.
In terms of susceptibility to antibiotics, the isolated strains were sensitive to clindamycin
with MICs ranging from 0.125 to <0.03125 µM. The same isolates exhibited medium sen-
sitivity to gentamicin and ciprofloxacin with MICs ranging from 0.5 to 8 µM. Most S. au-
reus isolates were resistant to oxytetracycline with a MIC of 128 µM. Most of the isolated
bacteria were resistant to polymyxin B with a MIC > 128 µM. With the exception of the A.
pyogenes isolates, all the isolated bacteria were sensitive to enrofloxacin with a MIC <1
µM.
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Hoe and Ruegg, 2005). However, determination of
antimicrobial sensitivity of mastitis pathogens is an
important tool for monitoring the development of
antimicrobial resistance (Pol and Ruegg, 2007).
There are limited published national surveys of the
antimicrobial susceptibilities of pathogens isolated
from dairy cattle in Egypt. The objective of this
study was to assess the antimicrobial susceptibility
of bacterial bovine and bubaline mastitis pathogens
isolated from cases admitted to the Veterinary
Teaching Hospital in Assiut, Egypt. The antibiotics
studied included gentamicin, polymyxin B, clin-
damycin, oxytetracycline, enrofloxacin and
ciprofloxacin. 
Materials and methods
Clinical examination
Eleven cases suffering from mastitis were ad-
mitted to the Veterinary Teaching Hospital- Faculty
of Veterinary Medicine- Assiut University, Assiut,
Egypt, during the months of January and February
(2014). The attending veterinarian examined each
case clinically and clinical symptoms (local signs
such as swelling and pain in the udder, milk appear-
ance, and systemic signs such as rectal temperature,
general attitude, and appetite) were recorded. These
cases included 5 buffaloes and 6 cows with teat le-
sions that resembled those of pseudo cowpox dis-
ease. All the studied cases were between the second
and fourth lactation seasons, cows were all native
breed and buffaloes were the Egyptian Bubalis
bubalis. Some of these cases showed lesions in one
quarter, others in two quarters and some with all
quarters affected. The disease, in most cases, ini-
tially began with lesions in the teats resembling
those observed with pseudo cowpox disease. Next,
milk from the affected quarter changed complexion
to form a pussy material. The affected quarter did
not respond to treatment, became blackish in color,
and eventually ended with sloughing of the teat.
These cases were treated with oxytetracycline and
penicillin; however there was no response to the
treatment. In several cases, the infection extended
to more than one quarter.
Sample collection and bacterial isolation 
For milk collection, udders of the clinical mas-
titis cow were washed with clean water and dried.
Cotton swabs soaked with 70% ethanol were used
to disinfect the surfaces of teats. The first few
streams of milk were discarded before a milk sam-
ple was collected into a 10-ml sterile plastic tube.
Samples sent directly to the laboratory in an ice
tank, and cultured at the same day of collection. 
Milk samples were inoculated on 5% sheep
blood agar plates and incubated at 37ºC for 24 h.
S. aureus identification was confirmed via gram
staining, morphology, and traditional biochemical
tests, including catalase, coagulase and mannitol
fermentation tests (Turk and Porter, 1978; Banner-
man, 2003). Other pathogens were identified using
laboratory procedures as defined by the National
Mastitis Council guidelines (NMC, 1999).
Antibacterial assays
The selected antimicrobial agents (gentamicin
and oxytetracycline (aminoglycosides), clin-
damycin (lincosamide), ciprofloxacin and en-
rofloxacin (fluoroquinolones) and polymyxin B
(polypeptide)) were provided as powders by VWR,
USA. The antimicrobial agents were subsequently
dissolved in suitable solvents to make stock of 10
mM solutions.
The minimum inhibitory concentration (MIC)
of each antibiotic was evaluated using the broth mi-
crodilution technique, in Mueller-Hinton broth
(MHB) with an initial bacterial inoculum of 5×105
CFU/mL in non-treated Polystyrene microtiter
plates, in accordance with the Clinical and Labo-
ratory Standards Institute (CLSI) guidelines (CLSI
2007). The MIC was interpreted as the lowest con-
centration of antibiotic that completely inhibit the
growth of bacteria after 16 h incubation of the
plates at 37°C. Each agent was tested in triplicate
in at least two independent experiments. The high-
est MIC value was reported.
Results
Clinical findings
The disease commenced with vesicle and ulcer-
ative lesions in the teats resembling those of pseudo
cowpox disease (Fig. 1). Next, milk from the af-
fected quarter changed to a pussy material; in some
cases, the lesions resulted in the loss of milk secre-
tion. Then the affected quarter did not respond to
treatment with antibiotics and the skin color
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changed to blue or black in color. Eventually, the
disease progressed to sloughing of the teat (Fig. 2).
These cases were treated in the field with oxytet-
racycline and penicillin with no response. In some
cases, the infection started in more than one quar-
ter, but in other cases, it extended from the diseased
quarter to other healthy quarters, resulting in
sloughing of the skin of the teat in all quarters es-
pecially in buffaloes (Fig. 3).
Isolated bacteria
Fifteen bacterial isolates were identified from
the cases, presented as 5 isolates of S. aureus
(33.33%), 5 isolates of Arcanobacterium pyogenes 
(33.33%), 2 isolates of Streptococcus agalactiae
(13.33%), 2 isolates of coagulase negative staphy-
lococci (13.33%) and one Klebseilla pneumoniae
isolate (6.67%) as shown in Fig. 4. S. aureus was
isolated alone in two cows (13.33% of the isolates).
S. aureus was isolated in combination with A. pyo-
genes in one buffalo (6.67%), and was isolated in
combination with both A. pyogenes and S. agalac-
tiae in two buffaloes (13.33%).  Coagulase-nega-
tive staphylococci (CNS) were isolated alone in a
single buffalo case (6.67%) and were isolated in
combination with Klebsiella pneumoniae in one
cow case (6.67%). A. pyogenes was isolated alone
in two cows (13.33%). In two cases (one cow and
one buffalo), we were not able to isolate any bac-
terial pathogens in spite of all quarters were af-
fected in these two cases and discharging pussy
milk.
Antimicrobial susceptibility
The antimicrobial susceptibilities of the ana-
lyzed bacterial isolates are presented in Table 1.
The isolated strains were sensitive to clindamycin
with a MIC between 2 to <0.03125 µM and showed
medium sensitivity against gentamicin and
ciprofloxacin with MICs ranging from 0.5 to 8 µM.
Most S. aureus isolates were resistant to oxytetra-
cycline with a MIC of 128 µM., additionally, most
of the isolated bacteria were resistant to polymyxin
B with a MIC > 128 µM. Nearly all the isolated
bacteria were sensitive to enrofloxacin with a MIC
<1 µM, some strains of A. pyogenes that only ex-
hibited medium sensitivity.
Fig. 1. Vesicles and ulceration in the teat with bluish discol-
oration of some areas on the teat. 
Fig. 2. Sloughing of the dead tissue of the teat and no milk
secretion.
Fig. 3. Infection extended to all quarters with blackish dis-
coloration of the teat skin and sloughing of the dead tissue.
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Discussion
Mastitis is the most prevalent disease of dairy
cows and remains one of the most common reasons
to remove cows from production (Pol and Ruegg,
2007). After developing mastitis, the probability of
a successful cure depends on multiple factors in-
cluding the immune system of the cow, virulence
characteristics of the pathogen, and the efficacy of
the treatment protocol. The development of antimi-
crobial resistance in mastitis pathogens is one fac-
tor that reduces the probability of cure (Oliveira et
al., 2012). Bacteria may be intrinsically resistant to
a specific class of antimicrobial due to a lack of an
appropriate binding site/target, other pharmacolog-
ical characteristics, or bacteria may acquire resist-
ance to antimicrobials by mutations in their
chromosomal genes or by exchange of genetic ma-
terial via plasmids or transposons (Neu, 1992).
Fig. 4. Percentage of the isolated bacteria from the bovine mastitis cases.
Table 1. Minimum inhibitory concentration (MIC) of antibiotics against 15 bacterial isolates that were isolated from 11 mas-
titis cases.
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Bacteriological examination of milk samples
has revealed that S. aureus is the predominant iso-
late in most mastitis cases especially in buffaloes.
This may support the veterinary importance of S.
aureus as a major cause of mastitis of dairy cows
and buffaloes. Several authors in previous studies
(Ali et al., 2008; Zaitoun, 2008; Tollersrud et al.,
2006) concluded that S. aureus is an extremely im-
portant etiologic agent responsible for serious intra-
mammary infection of all dairy ruminants,
including buffaloes.
We did not test the MIC for penicillin against
the isolated bacteria from our cases due to the fact
that these animals were previously treated with
penicillin were not responsive to this treatment.
Therefore, the causative bacteria seem to be resist-
ant to penicillin. Many studies from different coun-
tries have demonstrated that S. aureus strains
isolated from bovine mastitis cases tend to be
highly resistant to penicillin, a β-lactam antibiotic,
while resistance to other antimicrobials was usually
low (Erskine et al., 2004; Sabour et al., 2004; Vin-
tov et al., 2003; Erskine et al., 2002; Aarestrup et
al., 1995).
The second-highest degree of resistance to treat-
ment of mastitis was observed with oxytetracycline
(Guler et al., 2005). Our results showed high re-
sistance of S. aureus to oxytetracycline; these re-
sults are similar to published reports in Finland
(Myllys et al., 1998; Gianneechini et al., 2002).
One possible explanation for this phenomenon
could be that for many years tetracyclines have
been the most widely used antimicrobial class uti-
lized by farmers to treat any infection in their herd
(Gao et al., 2012). Resistance to tetracycline comes
in agreement with Pinto et al. (2013), and were de-
scribed previously in other countries (Savoia et al.,
2008; Martins et al., 2011), including in Brazil
(Corrêa et al., 2011). The rise of tetracycline resist-
ance is of concern since it is one of the main an-
timicrobials used in mastitis control (Keefe, 1997;
Tenhagen et al., 2006). Overuse and misuse of an-
tibacterial agents have been incriminated as the
major selective forces encouraging the develop-
ment of resistance in bacteria (WHO, 2002).
As resistance to penicillins and tetracycline
amongst bacteria isolates from mastitis cases, it is
critical to identify other antimicrobials that can be
utilized for treatment. Potential options which war-
rant further investigation include polymixin B, gen-
tamicin, and enrofloxacin. Polymyxin B is very
effective in treatment of infections caused by
Gram-negative bacteria. The mechanism of bacte-
ricidal activity of this agent is based on destabiliza-
tion of outer and inner cell membranes surrounding
the cells of Gram-negative bacteria (Galizzi et al.,
1975). Gram-positive bacteria are protected with a
thick cell wall composed of peptidoglycan (Galizzi
et al., 1975). Therefore, they are more resistant to
polymyxin B. Our findings confirmed that
polymyxin B could kill all the isolated bacteria
with the exception of S. aureus. These findings
come in contrast with (Boyen et al., 2012; Szweda
et al., 2014). Meanwhile most isolated strains
showed mild sensitivity to gentamicin, which is in
agreement with Boyen et al. and Szweda et al.’s re-
sults. Less data are available about trials using
polymyxin B as a therapeutic agent for treating
mastitis. Our investigation revealed low anti-
staphylococcal activity of this compound, indicat-
ing it may not be a suitable treatment for mastitis
cases caused by S. aureus. 
Yoshimura et al. (2002) stated that gentamicin
was the most active antimicrobial against S. aureus
isolated from bovine intramammary infections with
a MIC of 0.2 µg/ml. However, several of the tested
isolates were resistant to gentamicin. Additionally,
they found no isolates were resistant to clin-
damycin. Collectively, these results are similar to
our findings. Clindamycin was used in our study to
test for bacterial resistance against lincosamide an-
tibiotics; as with Yoshimura et al’s study, none of
the isolates we tested were resistant. Similar results
were obtained by Gianneechini et al. (2002).
Enrofloxacin, a fluoroquinolone compound, in-
hibits DNA gyrase (Shen, 1993). Enrofloxacin, like
other compounds in the quinolone class, has mod-
erate activity against the staphylococci, fair activity
against the streptococci, and good to excellent ac-
tivity against Gram-negative bacilli (Green and
Budsberg, 1993). Enrofloxacin was active against
all groups of organisms used in the present study.
The high susceptibility level of the isolated bacteria
to enrofloxacin may be due to its infrequent use in
cattle, in either intramammary or systemic admin-
istration, for treatment of mastitis. (Myllys et al.,
1998; Gianneechini et al., 2002) found similar re-
sults.
Conclusion
All the isolated mastitogenic bacteria were sen-
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sitive to enrofloxacin and clindamycin, which may
suggest those antibiotics for dealing with the mas-
titic cases.
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